This symposium will showcase state-of-the-art mechanistic insights and management strategies for kidney and urological complications in pediatric oncology. It will feature cutting-edge approaches and address gaps in early risk detection and timely intervention to improve cancer treatment tolerability, long-term outcomes and quality of life. View the agenda.

Intended Audience

Physicians, providers and researchers in nephrology, urology, pharmacology, oncology hematology and bone marrow transplant.

Symposium Schedule

• Thursday, March 19, 2026 – 4 p.m. to 7 p.m.
• Friday, March 20, 2026 – 7:30 a.m. to 4 p.m.

Call for Abstracts

Deadline: January 31, 2026

Abstract submissions are open to all health professionals, faculty, students and researchers.

• Mechanisms and management strategies for kidney complications and urological complications in pediatric oncology
• Quality improvement project to reduce anti-cancer therapies kidney complications that can improve patient outcomes
• Case reports of kidney complications in pediatric patients receiving anti-cancer therapies

Submit Abstracts

Symposium Agenda

Thursday, March 19

4:00 p.m. to 5:30 p.m.
Session 1 - Acute and long-term kidney complication of pediatric cancer treated patients

• Daniel Green, MD, Member, Cancer Survivorship Division of the Department of Oncology, St. Jude Children's Research Hospital
• Stuart Goldstein, MD, FAAP, FNKF, Professor of Pediatrics, Pediatric Nephrologist and Director for Acute Care Nephrology Program, Cincinnati Children's Hospital

5:30 p.m. to 7:00 p.m.
Reception - Nationwide Children's Hospital Conference Center

Friday, March 20

7:30 a.m. to 8:00 a.m.
Breakfast - Nationwide Children's Hospital Conference Center

8:00 a.m. to 10:00 a.m.
Session 2 - Nephrotoxicity limiting anti-cancer therapies - approaches to overcome challenges

• Patient Experience
• Stephanie Benoit, MD, MPH, Assistant Professor of Pediatrics and Pediatric Nephrologist (clinical focus in onco-nephrology), Cincinnati Children’s Hospital
• Navjot Pabla, PhD, Associate Professor Pharmacology, The Ohio State University

10:00 a.m. to 11:00 a.m.
Poster Presentations - Nationwide Children's Hospital Conference Center

11:00 a.m. to 12:15 p.m.
Session 3 - Advances on kidney tumors, surgical approaches and urinary tract complications

• Jennifer Aldrink, MD, Professor of Surgery, The Ohio State University and Pediatric Surgeon, Nationwide Children’s Hospital
• Daryl McLeod, MD, MS, Associate Professor of Urology, The Ohio State University and Pediatric Urologist, Nationwide Children’s Hospital

12:15 p.m. to 1:15 p.m.
Lunch and Nationwide Children’s SUPER Program Speakers (addressing the need to increase taskforce)

1:15 p.m. to 2:30 p.m.
Session 4 - Devising new therapies that are precise, curative and safe to kidneys by molecular mechanistic approaches

• Claudia Robles, PhD, Research Scientist, Nationwide Children’s Hospital
• Leah Siskind, PhD, Professor of Pharmacology and Toxicology, University of Louisville School of Medicine

2:30 p.m. to 3:30 p.m.
Poster Presentations - Nationwide Children’s Hospital Conference Center

3:30 p.m. to 4:30 p.m.
Session 5 - Improving health equity in cancer – is there a need to improve nephrology-oncology collaborations and taskforce?

• Speaker: TBD
• Closing remarks and poster awards